Steve Chabot bought Regeneron Pharmaceuticals Inc (NASDAQ: REGN)
Steve Chabot (R-OH), a U.S. Representative, has disclosed 1 trade in Regeneron Pharmaceuticals Inc (REGN) since 2015, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Steve Chabot bought $1,001 - $15,000 of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) on May 26, 2015. Since that trade, REGN is up +38.40% against the S&P 500 up +316.21%, an outperformance of -277.81%.
Data updated
Steve Chabot's REGN trades vs the price
REGN is up +38.40% since Steve Chabot bought on May 26, 2015, versus +316.21% for the S&P 500.
Performance since this trade
All Steve Chabot REGN trades
Steve Chabot & REGN trading FAQ
Is it legal for Steve Chabot to trade Regeneron Pharmaceuticals Inc (REGN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Regeneron Pharmaceuticals Inc (REGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Steve Chabot buy REGN?
Steve Chabot disclosed a purchase of $1,001 - $15,000 of Regeneron Pharmaceuticals Inc (REGN) on May 26, 2015, according to public STOCK Act filings.
How has REGN performed since Steve Chabot's trade?
Since Steve Chabot bought REGN on May 26, 2015, the stock is up +38.40%, versus +316.21% for the S&P 500 over the same period, an outperformance of -277.81%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional REGN trades?
Quantellect tracks every disclosed congressional trade in Regeneron Pharmaceuticals Inc (REGN) on the Regeneron Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Steve Chabot's REGN tradesAll congressional filings for Regeneron Pharmaceuticals IncSteve Chabot's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.